Company intelligence / Profile preview

Prequel

San Francisco, California, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Prequel is a preventative health technology company focused on early disease detection and longevity. Founded by Gabriel Otte, the former CEO of Freenome, the company leverages advanced diagnostic tools, including multi-omics and liquid biopsy, to identify signs of cancer, cardiovascular disease, and metabolic disorders before symptoms appear. Prequel's mission is to shift the healthcare paradigm from reactive treatment to proactive prevention by providing individuals with comprehensive health insights and personalized action plans. The company operates at the intersection of biotechnology, data science, and clinical medicine to extend human healthspan.

Therapeutic areas: OncologyCardiovascularOtherMetabolic Disorders
Modalities: Liquid biopsyMulti-omicsImagingData Science
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Prequel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prequel.

Explore the full profile